Guanidinoacetate inhibits glutamate uptake in rat striatum of rats at different ages

Neurochemical Research

Volumn 32, Issue 6, 2007, Pages 959-964

  Zugno, Alexandra I ^a   Oliveira, Diogo L ^a   Scherer, Emilene B S ^a   Wajner, Moacir ^a   Wofchuk, Susana ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

GAMT deficiency; Glutamate uptake; Guanidinoacetate; Metabolic disease; Taurine

Indexed keywords

GLUTAMIC ACID; GUANIDINOACETATE METHYLTRANSFERASE; GUANIDINOACETIC ACID; TAURINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SLICE;

AGING; ANIMALS; GLUTAMIC ACID; GLYCINE; MICROINJECTIONS; NEOSTRIATUM; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; TAURINE;

RATTUS;

EID: 34248143354     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9245-1     Document Type: Article

References (33)

1. Von Figura K, Hanefeld F, Isbrandt D, Stöckler-Ipsiroglu S (2001) Guanidinoacetate methyltransferase deficiency. In: ScriverCR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1897-1908
2. Leuzzi V, Bianchi MC, Tosetti M, Carducci C, Cerquiglini CA, Cioni G, Antonozzi I (2000) Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation). Neurology 55:1407-1409
3. Schulze A, Ebinger F, Rating D, Mayaetepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74:413-419
4. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1-105
5. Segovia G, Porras A, Del Arco F, Mora F (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech Ageing Dev 122:1-29
6. Maragakis NJ, Rothstein JD (2004) Glutamate trasporters: animal models to neurologic disease. Neurobiol Dis 15:461-473
7. Friedler RM (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Méd 48:1365-1375
8. Chen Y, Swnason RA (2003) Astrocytes and brain injury. J Crerbr Blood F Met 23:137-149
9. Della Corte L, Crichton RR, Duburs G, Nolan K, Tipton KF, Tirzitis G, Ward RJ (2002) The use of taurine analogues to investigate taurine functions and their potential therapeutic applications. Amino Acids 23:367-379
10. Gupta RC, Win T, Bittner S (2005) Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr Med Chem 12:2021-2039
11. Wang JX, Li Y, Zhang LK, Zhao J, Pang YZ, Tang CS, Zhang J (2005) Taurine inhibits ischemia/reperfusion-induced compartment syndrome in rabbits. Acta Pharmacol Sin 26:821-827
12. +-ATPase activity. Int J Devl Neuroscience 22:191-196
13. +-ATPase activity due to ozone exposure or cholesterol enrichment. J Nutr Sci Vitaminol 41:627-634
14. Folbergrova J, Haugvicova R, Mares P (2001) Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonosts. Brain Res 980:120-129
15. +-ATPase and creatine kinase activities in rat striatum. Met Brain Dis (in press)
16. Thomazi AP, Godinho GFRS, Rodrigues JM, Schwalm FD, Frizzo MES, Moriguchi E, Souza DO, Wofchuk ST (2004) Ontogenetic profile of glutamate uptake in brain structures slices from rats: sensitivity to guanosine. Mech Ageing and Dev 125:475-481
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-267
18. Saransaari P, Oja SS (2000) Taurine and neural cell damage. Amino acids 19:509-526
19. Maragakis NJ, Rothstein JD (2001) Glutamate transporters in neurologic disease. Arch Neurol 58:365-370
20. Mori A, Kohno M, Masumizu T, Nosa Y, Packer I (1996) Guanidino compounds generate reactive oxygen species. Biochem Mol Biol Int 40:135-143
21. Hiramatsu M (2003) A role for guanidino compounds in the brain. Mol Cell Biochem 244:57-62
22. Begni B, Brighina L, Sirtori E, Fumagalli L, Andreoni S, Beretta S, Oster T, Malaplate-Armand C, Isella V, Appolonio I, Ferrarese C (2004) Oxidatibe stress impairs glutamate uptake in fibroblasts from patients wuth Alzheimer's disease. Free Rad Biol Med 37:892-901
23. Sala G, Beretta S, Ceresa C, Mattavelli L, Zoia C, Tremolizzo L, Ferri A, Carri MT, Ferrarese C (2005) Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis. Neurochem Int 46:227-234
24. Szatkowski M, Barbour B, Attwell D (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348:443-446
25. Attwell D, Barbour B, Szatkowski M (1993) Nonvesicular release of neurotransmitter. Neuron 11:401-407
26. Rossi DJ, Oshima T, Attwell D (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403:316-321
27. Fariello RG, Golden GT, Pisa M (1982) Homotaurine (3-aminopropanesulfonic acid; 3APS) protects from the convulsivant and cytotoxic effect systemically administered kainic acid. Neurology 32:241-245
28. French ED, Venazzi A, Whetsell WO Jr, Schwarcz R (1986) Antiexcitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv Exp Med Biol 203:349-362
29. Trenkner E (1990) The role of taurine and glutamate during early postnatal cerebellar development of normal and weavermutant mice. Adv Exp Med Biol 268:239-244
30. Petrosian AM, Haroutounian JE (2000) Taurine as a universal carrier of lipid soluble vitamins: a hypothesis. Amino acids 19:409-421
31. Kontro P, Oja SS (1987) Taurine and GABA release from mouse cerebral cortex slices: effectes of structural analogues and drugs. Neurochem Res 12:475-482
32. Frosini M, Sesti C, Dragoni S, Valoti M, Palmi M, Dixon HBF, Machetti F, Sgaragli G (2003) Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. Brit J Pharmaco 138:1163-1171
33. +-ATPase impairment in the retina of diabetic rats. Amino acids 23:401-406